Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorADAMS, Paul
dc.contributor.authorALTES, Albert
dc.contributor.authorBRISSOT, Pierre
dc.contributor.authorBUTZECK, Barbara
dc.contributor.authorCABANTCHIK, Ioav
dc.contributor.authorCANCADO, Rodolfo
dc.contributor.authorDISTANTE, Sonia
dc.contributor.authorEVANS, Patricia
dc.contributor.authorEVANS, Robert
dc.contributor.authorGANZ, Tomas
dc.contributor.authorGIRELLI, Domenico
dc.contributor.authorHULTCRANTZ, Rolf
dc.contributor.authorMCLAREN, Gordon
dc.contributor.authorMARRIS, Ben
dc.contributor.authorMILMAN, Nils
dc.contributor.authorNEMETH, Elizabeta
dc.contributor.authorNIELSEN, Peter
dc.contributor.authorPINEAU, Brigitte
dc.contributor.authorPIPERNO, Alberto
dc.contributor.authorPORTO, Graca
dc.contributor.authorPRINCE, Dianne
dc.contributor.authorRYAN, John
dc.contributor.authorSANCHEZ, Mayka
dc.contributor.authorSANTOS, Paulo
dc.contributor.authorSWINKELS, Dorine
dc.contributor.authorTEIXEIRA, Emerencia
dc.contributor.authorTOSKA, Ketil
dc.contributor.authorVANCLOOSTER, Annick
dc.contributor.authorWHITE, Desley
dc.contributor.groupauthorContributors Hemochromatosis Int
dc.date.accessioned2018-07-05T18:06:46Z
dc.date.available2018-07-05T18:06:46Z
dc.date.issued2018
dc.description.abstractAlthough guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p. Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
dc.description.indexMEDLINE
dc.description.sponsorshipLa Jolla
dc.description.sponsorshipNovartis
dc.identifier.citationHEPATOLOGY INTERNATIONAL, v.12, n.2, p.83-86, 2018
dc.identifier.doi10.1007/s12072-018-9855-0
dc.identifier.eissn1936-0541
dc.identifier.issn1936-0533
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/27076
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofHepatology International
dc.rightsrestrictedAccess
dc.rights.holderCopyright SPRINGER
dc.subject.otherdiagnosis
dc.subject.otherdiseases
dc.subject.wosGastroenterology & Hepatology
dc.titleTherapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryCanadá
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryAlemanha
hcfmusp.affiliation.countryIsrael
hcfmusp.affiliation.countryNoruega
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countrySuécia
hcfmusp.affiliation.countryAustrália
hcfmusp.affiliation.countryDinamarca
hcfmusp.affiliation.countryPortugal
hcfmusp.affiliation.countryHolanda
hcfmusp.affiliation.countryBélgica
hcfmusp.affiliation.countryisoca
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisode
hcfmusp.affiliation.countryisoil
hcfmusp.affiliation.countryisono
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisose
hcfmusp.affiliation.countryisoau
hcfmusp.affiliation.countryisodk
hcfmusp.affiliation.countryisopt
hcfmusp.affiliation.countryisonl
hcfmusp.affiliation.countryisobe
hcfmusp.author.externalADAMS, Paul:Western Univ, Univ Hosp, London, ON, Canada
hcfmusp.author.externalALTES, Albert:Asociac Espanola Hemocromatosis, Santa Coloma, Spain
hcfmusp.author.externalBRISSOT, Pierre:Univ Hosp Pontchaillou, INSERM, Unit 1241, Rennes, France; Haemochromatosis Int, London, England
hcfmusp.author.externalBUTZECK, Barbara:Haemochromatosis Int, London, England; European Federat Assoc Patients Haemochromatosis, Seine, France; Haemochromatose Vereinigung Deutschland, Hurth, Germany
hcfmusp.author.externalCABANTCHIK, Ioav:Int Bioiron Soc, Schaumburg, IL USA; Hebrew Univ Jerusalem, Jerusalem, Israel
hcfmusp.author.externalCANCADO, Rodolfo:Santa Casa Med Sch Sao Paulo, Div Hematol, Sao Paulo, SP, Brazil
hcfmusp.author.externalDISTANTE, Sonia:Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway
hcfmusp.author.externalEVANS, Patricia:Haemochromatosis Int, London, England; European Federat Assoc Patients Haemochromatosis, Seine, France
hcfmusp.author.externalEVANS, Robert:Haemochromatosis Int, London, England; Brunel Univ, Sch Engn & Design, Dept Elect & Comp Engn, Uxbridge, Middx, England; Haemochromatosis Soc, Barnet, Herts, England
hcfmusp.author.externalGANZ, Tomas:Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
hcfmusp.author.externalGIRELLI, Domenico:Univ Verona, Dept Med, Veneto Reg Referral Ctr Iron Metab Disorders, Verona, Italy
hcfmusp.author.externalHULTCRANTZ, Rolf:Karolinska Inst, Dept Med, Unit Gastroenterol & Rheumatol, Stockholm, Sweden
hcfmusp.author.externalMCLAREN, Gordon:Univ Calif Irvine, Div Hematol Oncol, Irvine, CA USA
hcfmusp.author.externalMARRIS, Ben:Haemochromatosis Int, London, England; Haemochromatosis Australia, Meridan Plains, Australia
hcfmusp.author.externalMILMAN, Nils:Danish Haemochromatosis Assoc, Copenhagen, Denmark
hcfmusp.author.externalNEMETH, Elizabeta:Univ Calif Los Angeles, David Geffen Sch Med, Ctr Iron Disorders, Los Angeles, CA 90095 USA
hcfmusp.author.externalNIELSEN, Peter:Univ Med Ctr Hamburg, Inst Biochem & Mol Zellbiol, Hamburg, Germany
hcfmusp.author.externalPINEAU, Brigitte:Federat Francaise Assoc Malad Hemochromatose, Paris, France
hcfmusp.author.externalPIPERNO, Alberto:Univ Milano Bicocca, Dept Med & Surg, Ctr Rare Dis, Monza, Italy; Assoc Study Hemochromatosis & Iron Overload Dis, Monza, Italy
hcfmusp.author.externalPORTO, Graca:Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal; Hosp Santo Antonio, Ctr Hosp Porto, Porto, Portugal
hcfmusp.author.externalPRINCE, Dianne:Haemochromatosis Int, London, England; Haemochromatosis Australia, Meridan Plains, Australia
hcfmusp.author.externalRYAN, John:Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Oxford, England
hcfmusp.author.externalSANCHEZ, Mayka:Asociac Espanola Hemocromatosis, Santa Coloma, Spain
hcfmusp.author.externalSWINKELS, Dorine:Radboudumc, Dept Lab Med, Nijmegen, Netherlands
hcfmusp.author.externalTEIXEIRA, Emerencia:Haemochromatosis Int, London, England; Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal; Univ Porto, Fac Ciencias, Porto, Portugal; Assoc Portuguesa Hemocromatose, Porto, Portugal
hcfmusp.author.externalTOSKA, Ketil:Haemochromatosis Int, London, England; Norwegian Haemochromatosis Assoc, Bergen, Norway
hcfmusp.author.externalVANCLOOSTER, Annick:Univ Hosp Leuven, Louvain, Belgium; Haemochromatose Vereniging Vlaanderen, Leuven, Belgium
hcfmusp.author.externalWHITE, Desley:Haemochromatosis Int, London, England; Univ Plymouth, Plymouth, Devon, England
hcfmusp.citation.scopus39
hcfmusp.contributor.author-fmusphcPAULO CALEB JUNIOR DE LIMA SANTOS
hcfmusp.description.beginpage83
hcfmusp.description.endpage86
hcfmusp.description.issue2
hcfmusp.description.volume12
hcfmusp.origemWOS
hcfmusp.origem.pubmed29589198
hcfmusp.origem.scopus2-s2.0-85044480865
hcfmusp.origem.wosWOS:000430317500001
hcfmusp.publisher.cityNEW YORK
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceBacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330
hcfmusp.relation.referenceBardou-Jacquet E, 2015, J HEPATOL, V62, P682, DOI 10.1016/j.jhep.2014.10.025
hcfmusp.relation.referenceBrissot P, 2016, EXPERT REV GASTROENT, V10, P359, DOI 10.1586/17474124.2016.1119043
hcfmusp.relation.referenceDe Buck E, 2012, J HEPATOL, V57, P1126, DOI 10.1016/j.jhep.2012.04.040
hcfmusp.relation.referenceLiu J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003150
hcfmusp.relation.referenceNIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004
hcfmusp.relation.referenceOng SY, 2017, LANCET HAEMATOL, V4, pE607, DOI 10.1016/S2352-3026(17)30214-4
hcfmusp.relation.referencePietrangelo A, 2010, J HEPATOL, V53, P3
hcfmusp.relation.referenceVanclooster A, 2015, CLIN RES HEPATOL GAS, V39, P205, DOI 10.1016/j.clinre.2014.09.001
hcfmusp.scopus.lastupdate2024-05-11
relation.isAuthorOfPublicationc78fbf09-2a91-499f-862e-74830b3b5fab
relation.isAuthorOfPublication.latestForDiscoveryc78fbf09-2a91-499f-862e-74830b3b5fab
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_ADAMS_Therapeutic_recommendations_in_HFE_hemochromatosis_for_pCys282Tyr_C282YC282Y_2018.PDF
Tamanho:
332.53 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)